Norris Medicines Ltd

12 Jan 2026

Norris Medicines Ltd Shares Key Compliance Update for Q4 2025 📋

- Compliance certificate submitted for quarter ending December 31, 2025, under SEBI Regulation 74(5).

- Registrar and Transfer Agent Purva Sharegistry (India) Private Limited handled the process.

- Securities for dematerialization were processed (accepted/rejected) and communicated within timelines.

- Mutilated/cancelled certificates were verified and replaced in the register of members.

- Detailed list of dematerialized shares from October 1 to December 31, 2025, provided.

- Notable shareholders: D V S Raju (30 shares), Kiritbhai Jivanlal Shah (120 shares), Samir N Gupta (180 shares).

- Document signed by Praveenchand Bafna (Director) and Deepali Gaonkar (Compliance Officer).